Effect of drug load and lipid-wax blends on drug release and stability from spray-congealed microparticles

被引:3
作者
Ouyang, Hongyi [1 ]
Ang, Soon Jun [1 ]
Lee, Zong Yang [1 ]
Hiew, Tze Ning [1 ]
Heng, Paul Wan Sia [1 ]
Chan, Lai Wah [1 ]
机构
[1] Natl Univ Singapore, Dept Pharm, GEA NUS Pharmaceut Proc Res Lab, 18 Sci Dr 4, Singapore 117543, Singapore
关键词
Spray congealing; paraffin wax; lipid additive; drug release; stability; SOLID DISPERSIONS; MICROENCAPSULATION; MICROSPHERES; MASKING; TASTE; CLARITHROMYCIN; OPTIMIZATION; BITTERNESS; DELIVERY; DISSOLUTION;
D O I
10.1080/10837450.2022.2152048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was designed to evaluate paraffin wax as a potential controlled release matrix for spray congealing and its impact on drug release and stability of the microparticles. Paraffin wax can form a hydrophobic barrier to moisture and reduce drug degradation besides retarding drug release in the gastrointestinal tract. More hydrophilic lipid-based additives can be incorporated to modulate the drug release through the paraffin wax barrier. This study reports the findings of lipid-wax formulations at preserving the stability of moisture-sensitive drugs in spray-congealed microparticles. Aspirin-loaded microparticles formulated with different drug loads, lipid additives, and lipid:wax ratios were produced by spray congealing. Stearic acid (SA), cetyl alcohol (CA), and cetyl ester (CE) were the lipid additives studied. The microparticles were evaluated for yield, encapsulation efficiency, particle size, drug stability, and release. CE exhibited the greatest effect on increasing drug release, followed by CA and SA. Dissolution profiles showed the best fit to Weibull kinetic model. The degree of drug degradation was low, with CA imparting the least protective effect, followed by SA and CE. Paraffin wax is useful for preserving the stability of moisture-sensitive aspirin and retarding its release from spray-congealed microparticles. The addition of lipid additives modulated drug release without compromising drug stability.
引用
收藏
页码:1069 / 1082
页数:14
相关论文
共 63 条
[1]   NOVEL ORAL CONTROLLED-RELEASE MICROSPHERES USING POLYGLYCEROL ESTERS OF FATTY-ACIDS [J].
AKIYAMA, Y ;
YOSHIOKA, M ;
HORIBE, H ;
HIRAI, S ;
KITAMORI, N ;
TOGUCHI, H .
JOURNAL OF CONTROLLED RELEASE, 1993, 26 (01) :1-10
[2]   Formulation of Lipid-Based Tableted Spray-Congealed Microparticles for Sustained Release of Vildagliptin: In Vitro and In Vivo Studies [J].
Al Zahabi, Khaled H. ;
Ben Tkhayat, Hind ;
Abu-Basha, Ehab ;
Sallam, Al Sayed ;
Younes, Husam M. .
PHARMACEUTICS, 2021, 13 (12)
[3]   New spray congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances [J].
Albertini, Beatrice ;
Passerini, Nadia ;
Pattarino, Franco ;
Rodriguez, Lorenzo .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (01) :348-357
[4]   Solid Lipid Microparticles for Oral Delivery of Catalase: Focus on the Protein Structural Integrity and Gastric Protection [J].
Bertoni, Serena ;
Tedesco, Daniele ;
Bartolini, Manuela ;
Prata, Cecilia ;
Passerini, Nadia ;
Albertini, Beatrice .
MOLECULAR PHARMACEUTICS, 2020, 17 (09) :3609-3621
[5]   Different BCS Class II Drug-Gelucire Solid Dispersions Prepared by Spray Congealing: Evaluation of Solid State Properties and In Vitro Performances [J].
Bertoni, Serena ;
Albertini, Beatrice ;
Passerini, Nadia .
PHARMACEUTICS, 2020, 12 (06) :1-20
[6]   Glutathione-Loaded Solid Lipid Microparticles as Innovative Delivery System for Oral Antioxidant Therapy [J].
Bertoni, Serena ;
Albertini, Beatrice ;
Facchini, Carlotta ;
Prata, Cecilia ;
Passerini, Nadia .
PHARMACEUTICS, 2019, 11 (08)
[7]   Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study [J].
Bertoni, Serena ;
Albertini, Beatrice ;
Ferraro, Luca ;
Beggiato, Sarah ;
Dalpiaz, Alessandro ;
Passerini, Nadia .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 139 :132-141
[8]   Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (03) :375-388
[9]   FACTORS INFLUENCING THE RELEASE OF PEPTIDES AND PROTEINS FROM BIODEGRADABLE PARENTERAL DEPOT SYSTEMS [J].
BODMER, D ;
KISSEL, T ;
TRAECHSLIN, E .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :129-137
[10]  
BODMER D, 1996, Patent No. 5538739